the abeona therapeutics company is a disease leading gene therapy company. it is a disease leading gene therapy company, and its clinical development has been marked by notable achievements and advancements. we have expanded our program pipeline with the addition of a clinical stage asset. we reported on positive clinical data in our lead program for lysosomal storage diseases as well as our programs for epidermolysis bullosa. we have achieved multiple regulatory designations in multiple programs. we have stated that we are further developing our work in the library of next generation av viral vectors with our our our anim viral vector platforms.